Live Breaking News & Updates on Inselspital University Hospital|Page 3

Stay updated with breaking news from Inselspital university hospital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ENDRA Life Sciences Inc.: ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland


ENDRA Life Sciences Inc.: ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland
® Ultrasound Device in NAFLD Patients as Commercialization Begins
ANN ARBOR, MI / ACCESSWIRE / February 17, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that Inselspital University Hospital in Bern, Switzerland is partnering with ENDRA for a clinical study of ENDRA s Thermo Acoustic Enhanced UltraSound (TAEUS
®) device for assessing Non-Alcoholic Fatty Liver Disease (NAFLD).
We are very excited that Inselspital Bern, a renowned Swiss clinical and teaching institution, is evaluating TAEUS
® as a non-invasive tool to characterize NAFLD, a condition that impacts more than 1 billion people globally, said ENDRA Life Sciences Chief Commercial Officer Renaud Maloberti. ENDRA is honored to add this leading research institution to our growing list of ....

Annalisa Berzigotti , Renaud Maloberti , David Wells , Kim Sutton Golodetz , Inselspital University Hospital , Company Contact , Drug Administration , University Hospital Of Berne , University Clinic For Visceral Surgery , University Hospital Bern , Department For Biomedical Research , Exchange Commission , European Union , Life Sciences , Securities Exchange , Life Sciences Inc , Ge Healthcare , Bolster Clinical Performance Evidence , Ultrasound Device , Acoustic Enhanced Ultrasound , Non Alcoholic Fatty Liver Disease , Inselspital Bern , Sciences Chief Commercial Officer Renaud , Biomedical Research , University Clinic , Visceral Surgery ,